242714 ⎘
Sincalide Formulations
#2Sincalide Formulations
#3Sincalide Formulations
#4PARTICULATE MATERIALS
#5Sincalide Formulations
#6Sincalide Formulations
#7Particulate materials
#8Particulate materials
#9Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections
#10Analgesic pharmaceutical composition for oral administration
#11Particulate materials
#12Granular controlled release agrochemical compositions and process for the preparation thereof
#13Calcium phosphate cements and methods for using the same
#14Water-dispersible pellets
#15Tranexamic acid formulations
#16Tranexamic acid formulations
#17Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections
#18Water-dispersible pellets
#19DERMATOLOGICAL COMPOSITION
#20Sincalide Formulations
#21Particulate materials
#22Chemoablation of tissue using biodegradable, solid salt dosage forms
#23Water-dispersible pellets
#24AQUEOUS-BASED PHARMACEUTICAL COMPOSITION
#25Buoyant polymer particles for delivery of therapeutic agents to the central nervous system
#26Granular controlled release agrochemical compositions and process for the preparation thereof
#27Embolization
#28Carrier particles for use in dry powder inhalers
#29Aqueous-based pharmaceutical composition
#30Novel Process
#31MELT-EXTRUDED ORALLY ADMINISTRABLE OPIOID FORMULATIONS
#32Sincalide Formulations
#33Pharmaceutical formulations for intranasal administration of protein comprising a chitosan or a derivative thereof
#34Particulate materials
#35Method of targeting sustained release formulations of therapeutic agents to treat lung diseases
#36MELT-EXTRUSION MULTIPARTICULATES
#37Aqueous-based pharmaceutical composition
#38ORALLY ADMINSTRABLE OPIOID FORMULATIONS HAVING EXTENDED DURATION OF EFFECT
#39Tranexamic acid formulations
#40Porous polymeric particle comprising polyvinyl alcohol and having interior to surface porosity-gradient
#41Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections
#42Water-dispersible pellets
#43Enhancement of activity and/or duration of action of selected anti-inflammatory steroids for topical or other local application
#44ORALLY ADMINISTRABLE OPIOID FORMULATIONS HAVING EXTENDED DURATION OF EFFECT
#45Sustained Release Formulation of a Peptide
#46Pharmaceutical compositions containing lithium carbonate
#47ORALLY ADMINISTRABLE OPIOID FORMULATIONS HAVING EXTENDED DURATION OF EFFECT
#48Metal-containing materials
#49Method for the production of effervescent granules in a vacuum
#50Pharmaceutical composition containing an active ingredient and a micronised carrier/diluent
#51Chemoablation of tissue using biodegradable, solid salt dosage forms
#52Rapid Acting Drug Delivery Compositions
#53Pharmaceutical and diagnostic compositions containing nanoparticles useful for treating targeted tissues and cells
#54Calcium phosphate cements and methods for using the same
#55Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections
#56Method of inhibiting restenosis using bisphosphonates
#57Preparation of sterile aqueous suspensions comprising micronised crystalline active ingredients for inhalation
#58Pharmaceutical compositions comprising meloxicam and methods of their preparation
#59Matrices Formed of Polymer and Hydrophobic Compounds For Use in Drug Delivery
#60Granular controlled release agrochemical compositions and process for the preparation thereof
#61Granule baits
#62Aqueous-based pharmaceutical composition
#63Oral pharmaceutical delivery system with improved sustained release
#64Fast-dissolving pharmaceutical composition
#65Very high molecular weight β-glucans
#66Treatment of mucosal membranes
#67Powdery preparation for nasal administration
#68Fast disintegrating tablet
#69Pharmaceutical formulations for intranasal administration of protein comprising a chitosan or a derivative thereof
#70Therapeutic treatments using the direct application of antimicrobial metal compositions
#71Treatment of acne
#72Medicament composition and method of administration
#73Multiparticulate formulations of lithium salts for oral administration suitable for once-a-day administration
#74Carrier particles for use in dry powder inhalers
#75Calcium phosphate cements and methods for using the same
#76Stable spray-dried protein formulations
#77Treatment of inflammatory skin conditions
#78Directly compressible tricalcium phosphate
#79Aerosol composition
#80Tranexamic acid formulations
#81Method of protecting skin from UV radiation using a dermatological composition having porous silicon
#82Rapid acting drug delivery compositions
#83Pharmaceutical compositions containing lithium carbonate
#84Powders comprising anti-adherent materials for use in dry powder inhalers
#85Composition comprising a liquid absorbed on a support based on precipitated silica
#86Dry powders of metal-containing compounds
#87Methods of treating conditions with a metal-containing material
#88Water-dispersible pellets
#89Pharmaceutical and diagnostic compositions containing nanoparticles useful for treating targeted tissues and cells
#90Sustained-release composition of drugs encapsulated in microparticles of hyaluronic acid
#91Sustained release formulation of a peptide
#92Melt-extruded orally administrable opioid formulations
#93Chemoablation of tissue using biodegradable, solid salt dosage forms
#94Treatment of humans with colloidal silver composition
#95Control of process humidity to produce large, porous particles
#96Bismuth oxychloride compositions and methods of rinsing
#97Enhancement of activity and/or duration of action of selected anti-inflammatory steroids for topical or other local application
#98Sincalide formulations